Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CJC-1295 in HIV-Infected Patients with HIV-Associated Visceral Obesity
2005-003797-25Phase 2Terminated
- Sponsor
- ConjuChem
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lipodystrophy comparing CJC-1295 with Placebo (2 arms). Started Sep 2005; status: terminated.
02
Drugs
CJC-1295
03
Conditions
lipodystrophy
Beyond the preview
Go deeper on 2005-003797-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003797-25.